ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,309, issued on Oct. 7, was assigned to Baylor College of Medicine (Houston) and Wilson Wolf Manufacturing (New Brighton, Minn.).

"Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses" was invented by Ann Marie Leen (Houston), Ulrike Gerdemann (Cambridge, Mass.), Cliona M. Rooney (Bellaire, Texas), Juan F. Vera Valdes (Houston) and John R. Wilson (New Brighton, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention encompasses methods and compositions for the generation and use of cytotoxic T lymphocytes that target multiple viruses or that are specific for multiple tumor antigens. In specifi...